Hemeroteca


HIV Vaccine Trial Results An Opening for Further Research
February 4, 2010

By Raphael Dolin, M.D.
 
HIV-AIDS has emerged as an enormous, worldwide public health problem over the past 25 years. An estimated 33 million persons are infected with human immunodeficiency virus type 1 (HIV-1), and more than 7000 new infections occur every day. Although major advances have been made in the treatment of HIV-1 infection and in certain behavioral approaches to the prevention of HIV infection, ultimately, control will most likely depend on the development and application of a safe and effective HIV vaccine.

Substantial effort is being expended to develop an HIV vaccine through a variety of approaches. However, disappointing results have emerged from . .

Para ver el artículo completo dé click aquí.

Fuente: The New England Journal of Medicine.


Imprimir : HIV Vaccine Trial Results An Opening for Further Research